April 8, 2025
Mercy Awarded Funding to Expand AI-driven Smart-Texting Program
Mercy has been approved for a four-year funding award from the Patient-Centered Outcomes Research Institute (PCORI) through its Health Systems Implementation Initiative (HSII) to expand Mercy’s successful AI-driven, electronic patient-reported monitoring ...
March 18, 2025
Immunotherapy in Thyroid Eye Disease: Mercy Research Investigates Efgartigimod
Thyroid eye disease (TED) is an autoimmune condition primarily driven by autoantibodies that contribute to inflammation and tissue changes around the eyes. Patients with TED experience signs and symptoms that impact their quality of life such as proptosis...
March 10, 2025
Mercy Research Board of Directors Expands
Mercy Research Board of Directors has approved two voting board members to replace a resigned external board member and retiree Jacque Richmond, JD. Additionally, Mercy Research amended its bylaws to add two voting board members in recognition of growth w...
March 10, 2025
Investigating New Horizons in Hypothyroidism Treatment: Mercy Research Activates the M21-341 Study
Hypothyroidism has traditionally relied on synthetic T4 (levothyroxine) as a standard treatment. However, Mercy Research, along with Dr. Gregory Ledger, principal investigator for the M21-341 study and Mercy Springfield endocrinologist, is leading an exci...
October 3, 2024
Mercy Awarded Nearly $3 Million for Obesity Funding
Mercy received a nearly $3 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) through its Health Systems Implementation Initiative (HSII) to implement intensive lifestyle treatment programs for weight loss within primary c...
June 28, 2024
Mercy Data Supports FDA Authorization of AI Tool to Detect Life-Threatening Sepsis
The U.S. Food and Drug Administration (FDA) authorized a new tool called Sepsis ImmunoScore™, created by Prenosis, Inc. This tool uses artificial intelligence (AI) to detect sepsis, a serious and hard-to-diagnose response to infection. Mercy was one of 10...
June 28, 2024
Multi-Cancer Early Detection Blood Test May Increase Cancer Screening Equity
Cancer screenings save countless lives each year. While improved technology means more lives saved, reaching underserved and low-income communities can be difficult.
Dr. Gautum Agarwal, urologic oncologist and director of Mercy’s Office of Precision ...
June 27, 2024
Mercy Research Names Christina Hearty 2024 Outstanding Research Co-worker
Mercy Research recently named Christina Hearty, senior clinical research nurse for non-oncology in St. Louis, the 2024 Outstanding Research Co-worker of the Year. Her dedication and exceptional contributions were celebrated at Mercy Research’s summer gath...
May 22, 2024
Mercy Oncology Services Receives Innovator Award for Chen Chemotherapy Model
Mercy Oncology Services is one of the Association of Cancer Care Centers (ACCC) winners for its 14th annual ACCC Innovator Awards for its Chen Chemotherapy Model, a smart-texting platform for high-risk patients after chemotherapy that reduces emergency ro...
April 8, 2024
Mercy’s Dr. Jay Carlson Named Modern Healthcare Innovator
Mercy is proud to announce Dr. Jay Carlson was recognized by Modern Healthcare’ as one the Innovators for 2024.